Drug-drug interactions: Proof of relevance (Part II): cause of tolerability problems or noncompliance.

Authors :: Preskorn SH
Source :: Journal of psychiatric practice [J Psychiatr Pract] 2005 Nov; Vol. 11 (6), pp. 397-401.
Publication Year :: 2005

Subjects :: Antipsychotic Agents pharmacology
Basal Ganglia Diseases chemically induced
Cytochrome P-450 CYP2D6 Inhibitors
Cytochrome P-450 Enzyme System metabolism
Humans
Risperidone pharmacology
Selective Serotonin Reuptake Inhibitors pharmacology
Antipsychotic Agents adverse effects
Drug Interactions
Mental Disorders drug therapy
Risperidone adverse effects
Selective Serotonin Reuptake Inhibitors adverse effects
Treatment Refusal

Full Text Access

Tools